BTLS — Biotalys NV Cashflow Statement
0.000.00%
Annual cashflow statement for Biotalys NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -18.1 | -22.5 | -20.9 | -13.5 | -15.8 |
| Depreciation | |||||
| Non-Cash Items | 0.093 | 0.91 | 0.557 | 0.083 | 0.27 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.238 | -0.045 | 0.265 | -1.07 | 0.11 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.8 | -20.1 | -18.3 | -12.7 | -13.7 |
| Capital Expenditures | -1.33 | -0.707 | -0.455 | -0.138 | -0.182 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.008 | 0.023 | 0.688 | 0.715 | 0.29 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.32 | -0.684 | 0.233 | 0.577 | 0.108 |
| Financing Cash Flow Items | -0.245 | -0.245 | -0.158 | -0.156 | -0.105 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 51.1 | -1.24 | 5.53 | 13.1 | -1.03 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 33 | -22 | -12.5 | 1.07 | -14.6 |